Anti-Cardiolipin Phospholipid Antibodies (IgG) - Immunoassay
This blood test measures the presence of antibodies against cardiolipin, a phospholipid found in cell membranes. These antibodies may be linked to certain autoimmune conditions or blood clotting disorders.
["This test helps evaluate potential autoimmune or clotting-related risks."]
Key facts at a glance
- LOINC
- 34716-1
- Short code
- COXPH1
- Synonyms
- C burnet Ph1 IgG Titr Ser IF
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) or red-top tube without anticoagulant
- Units
- N/A
- Ref low
- 100
- Ref high
- 1
- Critical range
- — – 800 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Indirect Immunofluorescence Assay (IFA)
- CPT
- 86638
- SNOMED
- 395200008
- Specimen volume
- 1-2 mL of serum (minimum 0.5 mL)
- Stability
- Serum stable at room temperature for 24 hours; refrigerated (2-8°C) for 7 days; frozen (-20°C or lower) for long-term storage up to several months. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 48–168 hours
- Order
- routine
What Is This Test Measuring?
Cardiolipin is a type of fat (lipid) found in the cell membranes of certain tissues, including those in the heart and blood vessels. When the immune system mistakenly attacks these phospholipids, it produces antibodies called anti-cardiolipin antibodies. This test detects the presence of these antibodies in your blood.
Why Might Your Doctor Order This Test?
Doctors may recommend this test if you have symptoms or risk factors for autoimmune diseases (like lupus or rheumatoid arthritis) or blood clotting disorders (such as antiphospholipid syndrome). It may also be used to monitor conditions where these antibodies are suspected.
Common Conditions Linked to Positive Results
Positive results for anti-cardiolipin antibodies can be associated with autoimmune diseases, such as systemic lupus erythematosus (SLE) or antiphospholipid syndrome (APS), which increases the risk of blood clots. However, not everyone with these antibodies will develop symptoms.
What to Expect Before the Test
No special preparation is needed for this blood test. You may have a small needle inserted into your arm to draw blood, similar to other routine blood tests. If you’re on blood thinners or have a history of bleeding issues, let your doctor know before the test.
Reference range
Titer <1:100: Negative; Titer 1:100-1:200: Borderline/Past exposure; Titer 1:200-1:800: Suggestive of past or chronic exposure; Titer ≥1:800: Suggestive of chronic Q fever (especially infective endocarditis)N/A
No special patient preparation required. Acute and convalescent serum samples (drawn 2-4 weeks apart) are recommended for accurate diagnosis of acute Q fever. For chronic Q fever, a single specimen with Phase I IgG titer is typically diagnostic.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance: When This Test Matters
Short name
Anti-Cardiolipin Antibodies (IgG)
Frequently asked questions
What Are My Next Steps If My Results Are Abnormal?
Do I Need to Avoid Certain Foods or Supplements Before the Test?
Could This Test Be Related to Other Conditions?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy